Role of androgens in the growth of endometrial carcinoma: An in vivo animal model

Citation
Rs. Legro et al., Role of androgens in the growth of endometrial carcinoma: An in vivo animal model, AM J OBST G, 184(3), 2001, pp. 303-308
Citations number
28
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
ISSN journal
00029378 → ACNP
Volume
184
Issue
3
Year of publication
2001
Pages
303 - 308
Database
ISI
SICI code
0002-9378(200102)184:3<303:ROAITG>2.0.ZU;2-P
Abstract
OBJECTIVE: We sought to create an animal model for the development of endom etrial cancer in women with androgen excess. We examined the effects of est radiol and androgen, both alone and as precursors to estrogen biosynthesis on human endometrial cancers transplanted into a nude mouse model. STUDY DESIGN: We transplanted an estrogen-responsive, well-differentiated, established human endometrial carcinoma, EnCa-101, subcutaneously into athy mic male nude mice. We established, first, that aromatase was expressed in this cell line, inducible by estrogen. We measured the growth of the tumor in the various groups weekly with Vernier calipers. We examined the effects of estradiol and androgens, both aromatizable and nonaromatizable, on tumo r growth. RESULTS: Estrogen-supplemented tumors showed the greatest rate of growth an d were significantly greater than the growth rate in castrate mice. Androge n-supplemented tumors showed a growth rate similar to that of tumors withou t significant hormonal exposure (castrate mice). Dihydrotestosterone had no effect on tumor growth in comparison with an agonadal state. CONCLUSIONS: Aromatizable and nonaromatizable androgens have little growth- promoting effect on a well-differentiated endometrial carcinoma. Estradiol is the most potent growth stimulus in our model.